Introduction {#sec1}
============

Cardiopulmonary exercise testing (CPET) is used for clinical evaluation of pulmonary and cardiocirculatory abnormalities, breathlessness (termed dyspnea), and exercise tolerance in patients with chronic conditions ([@ref39]). CPET is a helpful diagnostic tool that can aid clinicians to identify patterns of functional impairment that may not be recognized by resting physiological testing (i.e., pulmonary function test, echocardiogram) and is particularly well suited to understand factors that may lead to pulmonary-related limitations to exercise ([@ref50]). Further, emerging research suggests that resting physiological tests poorly predict exertional dyspnea and exercise intolerance in clinical populations and that CPET is vital to evaluate causes of previously unexplained dyspnea and exercise intolerance ([@ref7], [@ref8]; [@ref31]; [@ref4]).

During exercise, ventilation (*V˙* ~E~) increases in proportion to metabolic demand \[i.e., carbon dioxide production (*V˙*CO~2~)\] in order to maintain acid-base balance. The response of *V˙* ~E~ relative to *V˙*CO~2~ (*V˙* ~E~/*V˙*CO~2~), said to reflect ventilatory efficiency ([@ref15]), has become a common physiological tool, in conjunction with other key variables such as operating lung volumes and subjective dyspnea ratings, to evaluate exercise responses in patients with chronic conditions. For clinicians to incorporate ventilatory efficiency into CPET interpretation, a thorough understanding of the background physiology of ventilatory efficiency is needed. This article provides a detailed review on the underlying physiology, measurement, and interpretation of exercise ventilatory efficiency during CPET. Additionally, exercise ventilatory efficiency in varying disease conditions is briefly discussed.

Ventilatory Responses During Exercise {#sec2}
-------------------------------------

Alveolar ventilation (*V˙* ~A~) represents the ventilation which takes part in gas-exchange. The relationship between *V˙* ~A~, CO~2~ production (*V˙*CO~2~), and the partial pressure of alveolar CO~2~ (P~A~CO~2~) is defined by$$P_{A}{CO}_{2} = \left( {V˙{CO}_{2}/V˙} \right)_{A} \times K\ $$

where *K* is a conversion factor (normally = 863) used to adjust *V˙*CO~2~ from standard temperature and pressure dry (STPD) to body temperature, ambient pressure, saturated (BTPS). As demonstrated by [equation (1)](#EQ1){ref-type="disp-formula"}, P~A~CO~2~ is determined by the relative balance of *V˙*CO~2~ and *V˙* ~A~. Due to the difficulty in measuring P~A~CO~2~, arterial PCO~2~ (P~a~CO~2~) is often used as a surrogate with the assumption that P~A~CO~2~ ≈ P~a~CO~2~ ([@ref10]). Well-matched alveolar ventilation to perfusion is critical to maximize ventilatory efficiency and minimize dead space ventilation ([@ref57]; [@ref58]). Although the healthy lung generally has good matching of ventilation to perfusion ([@ref57]; [@ref59]), a portion of gas remains in the conducting airways and does not participate in gas-exchange, and is termed anatomical dead space. Alveolar dead space represents the fraction of alveoli that are ventilated but not perfused. Dead space ventilation is the sum of alveolar and anatomical dead space, and, thus total minute ventilation is the sum of alveolar and dead space ventilation, as displayed in [equation (2)](#EQ2){ref-type="disp-formula"}:$$V˙_{E} = V˙_{A} + V˙_{D}$$

Minute ventilation is measured at the mouth with expired gas analysis; however, *V˙* ~A~ and *V˙* ~D~ are more difficult to determine. If arterial blood gas and expired gas data are available, it is possible to derive *V˙* ~A~ from [equation (1)](#EQ1){ref-type="disp-formula"}, or estimate total physiologic dead space as a proportion of tidal volume using Enghoff's modified Bohr equation ([@ref10]):$$V_{D}/V_{T} = \left( {P_{a}{CO}_{2} - P_{E}{CO}_{2}} \right)/\left( {P_{a}{CO}_{2}} \right)$$

In [equation (3)](#EQ3){ref-type="disp-formula"}, P~E~CO~2~ represents mixed expired partial pressures of CO~2~ and *V* ~T~ is tidal volume. It is often assumed that the end-tidal partial pressure of CO~2~ (P~ET~CO~2~) can be used as a surrogate for P~a~CO~2~. However, previous research has shown discrepancies between arterial blood-gas derived P~a~CO~2~ and expired-gas derived P~ET~CO~2~ in patients with pulmonary gas-exchange abnormalities ([@ref47]; [@ref27]; [@ref7]). Ventilation-perfusion (*V˙* ~A~/*Q˙*) abnormalities (typically alveolar dead space) results in dilution of gas from poorly perfused alveoli, which lowers the end-tidal CO~2~ concentration. As a result, P~ET~CO~2~ often underestimates P~a~CO~2~ in patients with increased alveolar dead space such as pulmonary hypertension (PH) and chronic obstructive pulmonary disease (COPD; [@ref47]; [@ref27]; [@ref7]). Because of the potential error in determining P~a~CO~2~ from end-tidal data, care should be given when interpreting dead space calculated only with end-tidal and mixed expired values.

Based on the equations outlined above, the total ventilatory requirement to remove metabolic CO~2~ production (*V˙* ~E~/*V˙*CO~2~) is elevated in the presence of alveolar hyperventilation and/or high dead space. In conditions of hyperventilation assuming normal dead space, *V˙* ~E~/*V˙*CO~2~ would be elevated and P~a~CO~2~ lowered ([Figure 1](#fig1){ref-type="fig"}). As discussed below, many clinical conditions demonstrate hyperventilation during exercise, secondary to increased afferent feedback (including but not limited to skeletal muscle ergoreceptors, chemoreceptors, and baroreceptors) ([@ref42], [@ref41]; [@ref48]; [@ref14]). In conditions of increased total physiologic dead space (i.e., high *V* ~D~/*V* ~T~) during exercise, *V˙* ~E~ must increase to maintain adequate *V˙* ~A~ and blood gas homeostasis (i.e., P~a~CO~2~; [Figure 1](#fig1){ref-type="fig"}). In addition to classic alveolar dead space (i.e., ventilation with no perfusion), *V* ~D~/*V* ~T~ will be elevated when patients adopt a shallow, tachypneic breathing response. Hyperventilation also results in a rightward shift in the overall *V˙* ~A~/*Q˙* relationship which can directly increase *V* ~D~/*V* ~T~ ([@ref56]; [@ref44]). In many chronic diseases, both elevated dead space and alveolar hyperventilation coexist ([Figure 1](#fig1){ref-type="fig"}) and, without measurement of P~a~CO~2~, it becomes difficult to quantify the contribution of each.

![Ventilatory and gas-exchange responses to incremental exercise. The left columns **(A,D,G)** display theoretical normal responses (open circles) and abnormal responses (closed circles). The theoretical abnormal responses demonstrate an elevated ventilatory response to carbon dioxide output (*V˙* ~E~/*V˙*CO~2~), secondary to elevated dead space (dead space to tidal volume ratio = *V* ~D~/*V* ~T~) and normal partial pressure of arterial carbon dioxide (P~a~CO~2~). The middle columns **(B,E,H)** display theoretical normal responses (open circles) and abnormal responses (closed circles). The theoretical abnormal responses demonstrate an elevated *V˙*~E~/*V˙*CO~2~, secondary to alveolar hyperventilation (reduced P~a~CO~2~) but relatively normal dead space. The right columns **(C,F,I)** display theoretical normal responses (open circles) and abnormal responses (closed circles). The theoretical abnormal responses demonstrate an elevated *V˙* ~E~/*V˙*CO~2~, secondary to a combination of alveolar hyperventilation (reduced P~a~CO~2~) and elevated dead space.](fphys-11-00659-g001){#fig1}

Clinical Significance of Ventilatory Efficiency {#sec3}
-----------------------------------------------

It is accepted that perceived dyspnea increases as ventilatory demand rises during incremental exercise, even in healthy individuals ([@ref36],[@ref37]; [@ref13]). Ventilatory inefficiency increases the ventilatory demand for a given metabolic load which results in: (1) earlier attainment of critical dynamic mechanical constraint (i.e., critically reduced inspiratory reserve volume) and (2) increased respiratory neural drive, both of which lead to heightened perceived dyspnea and exercise intolerance, even in individuals with relatively preserved airway function ([@ref18]; [@ref12]). Multiple studies have linked ventilatory inefficiency to abnormal exertional dyspnea and poor exercise capacity in varying cardiocirculatory and respiratory diseases ([@ref20]; [@ref3]; [@ref32], [@ref31]; [@ref8]; [@ref11]). Additionally, the elevated *V˙* ~E~/*V˙*CO~2~ response to exercise is an independent predictor of poor outcomes and mortality in many diseases, including chronic heart failure (CHF), PH, and COPD ([@ref41]; [@ref55]; [@ref31]). Thus, the clinical utility of assessing ventilatory efficiency during CPET may be helpful to explain reasons for exertional dyspnea and exercise intolerance in various underlying disease states.

Measuring and Interpreting Ventilatory Efficiency From Cpet {#sec4}
===========================================================

*V˙* ~E~/*V˙*CO~2~ is easily included in a standard CPET report; however, careful consideration must be taken when analyzing and interpreting the data. This section describes common methods of reporting ventilatory efficiency from CPET data and technical considerations that may influence interpretation.

*V˙*~E~-to-*V˙*CO~2~ Slope and *y*-Intercept {#sec5}
--------------------------------------------

During incremental exercise to symptom limitation, the relationship between *V˙* ~E~ and *V˙*CO~2~ can be reported by plotting *V˙* ~E~ (*y*-axis) relative to *V˙*CO~2~ (*x*-axis, [Figure 2](#fig2){ref-type="fig"}). The *V˙* ~E~-to-*V˙*CO~2~ relationship during exercise can then be determined by analyzing the slope of this regression line ([@ref59]). Previous research has shown that the *V˙* ~E~-to-*V˙*CO~2~ slope lower and upper limits of normal range from approximately 21 to 31 units, respectively ([@ref52]; [@ref29]). The *V˙* ~E~-to-*V˙*CO~2~ slope is considered one of the most robust indicators of ventilatory efficiency, assuming ventilatory responses are not impaired by abnormal ventilatory mechanics ([@ref33]).

![Theoretical gas-exchange **(A, B)** and ventilatory **(C)** responses to incremental exercise. **(D)** represents the ventilatory responses to increasing metabolic demand. P~a~CO~2~ = partial pressure of arterial carbon dioxide; *V* ~D~/*V* ~T~ = deadspace to tidal volume ratio; *V˙* ~E~/*V˙*CO~2~ = ventilatory equivalent for carbon dioxide; AT = anaerobic threshold. Data points within grey shading represent the values used to calculate the slope of the regression line (note, the final two data points were excluded in the calculation as they occurred after the respiratory compensation point). The dashed line in **(D)** represents linear interpolation to the *y*-intercept.](fphys-11-00659-g002){#fig2}

During light to heavy exercise, *V˙* ~E~ changes as a linear function of *V˙*CO~2~. Importantly, at heavy exercise above the respiratory compensation point, *V˙* ~E~ rises disproportionally to *V˙*CO~2~ due to excessive metabolic acidosis. In individuals who tolerate high levels of exercise, an upward inflection in the *V˙* ~E~ relative to *V˙*CO~2~ response would occur at maximal exercise and would inflate the *V˙* ~E~-to-*V˙*CO~2~ slope if all data points are included in analysis. In these cases, determination of the slope of the regression line should exclude the non-linear portion (i.e., data after the respiratory compensation point should be excluded) ([@ref2]; [@ref17]).

When analyzing the *V˙* ~E~-to-*V˙*CO~2~ slope in respiratory disease, such as COPD, the interpretation becomes more complex. Respiratory mechanical constraint and airflow limitation are often observed in these patients, which can blunt the rise in ventilation during exercise. As such, the *V˙* ~E~-to-*V˙*CO~2~ slope paradoxically decreases as COPD severity worsens ([@ref32]) (see section COPD Chronic Obstructive Pulmonary Disease). Thus, clinicians must look beyond the *V˙* ~E~-to-*V˙*CO~2~ slope when evaluating ventilatory efficiency from CPET, especially in patients with respiratory mechanical constraints.

In addition to the slope, the *y*-intercept of the *V˙* ~E~-to-*V˙*CO~2~ relationship (i.e., *V˙* ~E~ when *V˙*CO~2~ = 0) can be determined from the same regression analysis ([Figure 2](#fig2){ref-type="fig"}). An elevated *y*-intercept is indicative of an upward shift in *V˙* ~E~ for a given *V˙*CO~2~ and is considered to be an index of ventilatory efficiency at rest and during light exercise (i.e., at the start of a CPET) ([@ref32]). The *y*-intercept can be a useful tool in the event of a premature test termination, as a maximal effort is not required. Recent research has demonstrated the *y*-intercept may help differentiate CPET patterns between COPD and CHF with overlapping symptoms (i.e., dyspnea and exercise intolerance), as COPD patients consistently demonstrate an elevated *y*-intercept, compared to CHF ([@ref49]).

*V˙* ~E~/*V˙*CO~2~ Nadir {#sec6}
------------------------

Generally, in the transition from light to moderate intensity exercise, P~a~CO~2~ remains constant or slightly increases, while V~D~/V~T~ decreases. As a result, the *V˙* ~E~/*V˙*CO~2~ ratio is elevated during light exercise at the start of a CPET and progressively decreases in tandem with *V* ~D~/*V* ~T~ to its lowest value (nadir) just prior to the respiratory compensation point ([Figure 2](#fig2){ref-type="fig"}; [@ref59]). The nadir *V˙* ~E~/*V˙*CO~2~ is often considered the most accurate assessment of ventilatory efficiency, as it occurs independent of (1) the excess *V˙* ~E~/*V˙*CO~2~ response to low intensity exercise and (2) metabolic acidosis and respiratory compensation during heavy exercise ([@ref59]). In healthy individuals, the *V˙* ~E~/*V˙*CO~2~ corresponding to the nadir and the *V˙* ~E~/*V˙*CO~2~ at anaerobic threshold are often similar ([Figure 2](#fig2){ref-type="fig"}; [@ref52]). The nadir *V˙* ~E~/*V˙*CO~2~ increases progressively with age and is abnormally high in cardiocirculatory and respiratory disease ([@ref52]; [@ref21]; [@ref7], [@ref9]; [@ref32]; [@ref40]). Although the nadir *V˙* ~E~/*V˙*CO~2~ is highly reproducible, it may over-estimate ventilatory inefficiency in individuals with poor exercise tolerance and an excessively short test duration during CPET ([@ref34]).

*V˙* ~E~/*V˙*CO~2~ at Peak Exercise {#sec7}
-----------------------------------

At peak exercise, *V˙* ~E~/*V˙*CO~2~ is often much higher than the nadir value as individuals typically hyperventilate secondarily to excessive metabolic acidosis ([Figure 2](#fig2){ref-type="fig"}). However, in individuals with poor exercise tolerance who are generally unable to exercise above anaerobic threshold, the nadir and peak exercise *V˙* ~E~/*V˙*CO~2~ values are often similar ([@ref32]; [@ref40]). Peak exercise *V˙* ~E~/*V˙*CO~2~ is considered a poor index of ventilatory efficiency in healthy individuals and in patients who can exercise above the anaerobic threshold ([@ref33]). For these reasons, clinicians should use caution when using peak exercise *V˙* ~E~/*V˙*CO~2~ values as an index of ventilatory efficiency.

Ventilatory Efficiency in Various Conditions {#sec8}
============================================

Healthy Aging {#sec9}
-------------

Healthy aging is associated with an increased *V˙* ~E~/*V˙*CO~2~ (slope and nadir) response to exercise, when compared to younger healthy individuals ([@ref52]; [@ref13]). The elevated *V˙* ~E~/*V˙*CO~2~ response is likely due to increased dead space, secondary to age-related reductions in alveolar-capillary surface area, capillary blood volume, and *V˙* ~A~/*Q˙* mismatch ([@ref54]; [@ref43]; [@ref23]; [@ref5]). However, age-related ventilatory inefficiency is generally not a primary cause of exercise limitation in older healthy individuals.

Chronic Heart Failure {#sec10}
---------------------

Multiple studies have demonstrated that patients with CHF with reduced ejection fraction (HFrEF) have an elevated ventilatory response to exercise, which is a key contributor to exertional dyspnea and exercise intolerance. The elevated *V˙* ~E~/*V˙*CO~2~ (slope and nadir) is generally ascribed to hyperventilation, secondary to increased afferent feedback from chemoreceptors, baroreceptors, and ergoreceptors ([@ref42], [@ref41]; [@ref48]). CHF patients typically adopt a rapid-shallow breathing pattern, which would increase the *V* ~D~/*V* ~T~ ratio and contribute to a greater *V˙* ~E~/*V˙*CO~2~ ([@ref60]). As described above, part of the increased *V* ~D~/*V* ~T~ in CHF is likely due to the hyperventilation itself, which results in a rightward shift of a normal *V˙* ~A~/*Q˙* distribution to a higher mean *V˙* ~A~/*Q˙* ratio, and greater dead space ([@ref44]). The contribution of both hyperventilation (low P~a~CO~2~) and elevated dead space contributing to an exaggerated *V˙* ~E~/*V˙*CO~2~ is demonstrated by [@ref22] who further analyzed individual CHF exercise data from [@ref16]. A low peak P~a~CO~2~ was associated with a high peak *V˙* ~E~/*V˙*CO~2~. Of note, a low cardiac index was also associated with a high *V˙* ~E~/*V˙*CO~2~ (suggesting those with a low cardiac output likely have a higher mean *V˙* ~A~/*Q˙* ratio and thus greater dead space). Finally, a high *V* ~D~/*V* ~T~ ratio was correlated with a high *V˙* ~E~/*V˙*CO~2~ ([@ref16]; [@ref22]). When combined, these data suggest both hyperventilation and increased dead space contribute to the increased *V˙* ~E~/*V˙*CO~2~ during exercise in CHF.

Emerging work has demonstrated ventilatory inefficiency (elevated *V˙* ~E~-to-*V˙*CO~2~ slope) in patients with CHF with preserved ejection fraction (HFpEF; [@ref38]); however, the mechanism(s) for the elevated *V˙* ~E~/*V˙*CO~2~ is unclear. Patients with HFpEF often have co-existing PH ([@ref24]), which may help explain the elevated *V˙* ~E~-to-*V˙*CO~2~ slope; however, future work is required to better understand the pulmonary gas-exchange abnormalities in this population.

Pulmonary Hypertension {#sec11}
----------------------

PH is characterized by a heightened ventilatory response to exercise (i.e., elevated *V˙* ~E~-to-*V˙*CO~2~ slope) ([@ref53]; [@ref61]). Patients with PH demonstrate significant ventilation-perfusion abnormalities, which is evident by an increased mean *V˙* ~A~/*Q˙* ratio, larger than normal arterial-end-tidal PCO~2~ differences, and increased dead space (*V* ~D~/*V* ~T~), all of which contribute to the elevated *V˙* ~E~/*V˙*CO~2~ response during exercise ([@ref6]; [@ref61]; [@ref25]). Although elevated dead space is generally considered the primary reason for ventilatory inefficiency in PH, previous work has shown that these patients hyperventilate at rest (as demonstrated by a low P~a~CO~2~) and demonstrate significant hyperventilation during exercise ([@ref25], [@ref26]; [@ref14]). Like CHF, patients with PH often have a blunted cardiac output response to exercise. The combination of low cardiac output and hyperventilation would cause a similar upward shift in the mean *V˙* ~A~/*Q˙* ratio as observed in CHF, which may partially explain the elevated dead space typically observed in PH ([@ref6]). When combined, it is evident that the increased *V˙* ~E~/*V˙*CO~2~ response to exercise in PH is explained by both hyperventilation and increased dead space. Readers are referred to a review by [@ref44] that provides an excellent summary of current understanding of factors contributing to exercise hyperventilation in patients with cardiocirculatory disease.

Chronic Obstructive Pulmonary Disease {#sec12}
-------------------------------------

Airflow limitation, secondary to dynamic respiratory mechanical abnormalities, is generally considered the primary cause of exertional dyspnea in COPD. However, emerging research has suggested that ventilatory inefficiency is also a key contributor to dyspnea and exercise intolerance in patients with COPD ([@ref32]; [@ref9]). In a study examining patients with mild COPD, arterial blood gas-derived dead space and *V˙* ~E~/*V˙*CO~2~ (slope, nadir, and *y*-intercept) were consistently elevated during exercise while P~a~CO~2~ and alveolar ventilation were similar to age-matched healthy controls ([@ref7]). These data suggest that ventilatory inefficiency during exercise in mild COPD is primarily due to elevated dead space.

With advancing COPD (moderate to very severe), the *V˙* ~E~/*V˙*CO~2~ response to exercise is more complex. With increasing COPD severity, dead space increases and is markedly elevated in the presence of extensive emphysematous destruction of capillary beds ([@ref45]). In these patients, the elevated anatomical and total dead space is further amplified by the adopted rapid and shallow breathing pattern, secondary to severe hyperinflation, critically low inspiratory reserve volume, and limited tidal volume expansion ([@ref35]). Additionally, patients with COPD often become hypoxemic ([@ref51]), which would stimulate peripheral chemoreceptors and further increase ventilatory drive. The pronounced dead space and reduced P~a~O~2~ combined with a rapid shallow breathing would result in a substantially elevated *V˙* ~E~/*V˙*CO~2~ response at rest and during light exercise; however, the pronounced airflow limitation in these patients often results in an inability to increase ventilation appropriately at higher metabolic demands. The net result is that patients with moderate to very severe COPD typically demonstrate an increased *V˙* ~E~-to-*V˙*CO~2~ *y*-intercept and nadir *V˙* ~E~/*V˙*CO~2~ but low *V˙* ~E~-to-*V˙*CO~2~ slope and *V˙* ~E~/*V˙*CO~2~ at peak exercise ([@ref32]).

Interstitial Lung Disease {#sec13}
-------------------------

A growing body of research has shown that pulmonary gas-exchange abnormalities and ventilatory inefficiency (i.e., elevated *V˙* ~E~/*V˙*CO~2~ slope and nadir) are key mechanisms of dyspnea and exercise intolerance in patients with interstitial lung disease (ILD; [@ref12]; [@ref46]). The increased *V˙* ~E~/*V˙*CO~2~ during exercise in ILD appears to be due to the combination of increased dead space and hyperventilation ([@ref1]; [@ref12]). During exercise in patients with ILD, dynamic restrictive mechanical constraints, secondary to increased lung elastic recoil, increase inspiratory elastic loading, and patients often adopt a more rapid and shallow breathing pattern during exercise to minimize the inspiratory elastic work of breathing ([@ref12]; [@ref46]). Although the reduction in tidal volume is an effective strategy to minimize the elastic work of breathing during exercise, the compensatory tachypnea increases anatomical dead space and, ultimately, *V˙* ~E~/*V˙*CO~2~ ([@ref12]; [@ref46]).

Multiple studies have consistently shown that patients with ILD develop exercise-induced arterial hypoxemia, which would stimulate the peripheral chemoreceptors and increase ventilatory drive, ultimately increasing *V˙* ~E~/*V˙*CO~2~ ([@ref19]; [@ref1]; [@ref12]). Patients with ILD, specifically idiopathic pulmonary fibrosis, often have PH which may worsen pulmonary gas-exchange and exacerbate the already elevated ventilatory response to exercise ([@ref28]; [@ref30]); however, future work is required to better understand how abnormal pulmonary hemodynamics affects pulmonary gas-exchange in this population.

Conclusions {#sec14}
===========

Measurement of ventilatory efficiency, as determined by the *V˙* ~E~/*V˙*CO~2~ response to exercise, is an important physiological component, in conjunction with other key variables, to evaluate exercise responses and help explain reasons for exertional dyspnea in different underlying disease states. While measurements of ventilatory efficiency can aid clinicians to interpret CPET results, it is important to understand the strengths and limitations of the various methods of interpreting ventilatory efficiency data and understand the underlying pathophysiology.
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